EXPANDED TABLE OF CONTENTS
VOLUME 9, NUMBER 5 MAY 2006
|
| TREATMENT HIGHLIGHTS |
| BRIGHT-LIGHT THERAPY FOR EARLY-MORNING AWAKENING INSOMNIA |
| Evening bright-light therapy is found to be beneficial in cases of early-morning awakening insomnia.
|
| PERIMENOPAUSE AND DEPRESSION |
| Among women with no history of depression, transition to menopause, as well as hormonal changes, are found to be associated with an increased risk of depression.
|
| SMOKING CESSATION AND WEIGHT GAIN
|
| Among adults who quit smoking cigarettes, increased appetite or weight gain as a withdrawal symptom is found to be associated with an increase in body mass index (BMI).
|
| QUICKSTATS |
| 2006 "Sleep In America" Poll |
| PSYCHOPHARMACOLOGY NOTE |
| METHYLPHENIDATE FOR HYPERACTIVITY IN CHILDREN WITH PERVASIVE DEVELOPMENTAL DISORDERS |
| In patients with pervasive developmental disorders (PDDs), methylphenidate is found to be effective in treating hyperactivity. However, the effect appears to be weaker than that which is seen with typically developing children with attention-deficit/hyperactivity disorder (ADHD), and there appears to be a higher occurrence of adverse events. |
| FDA NEWS AND REVIEW |
| Approval (new drug) of Chantix (varenicline tartrate). Indication: aid to smoking cessation treatment.
|
| Approval (new drug) of Vivitrol (naltrexone for extended-release injectable suspension). Indication: treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with Vivitrol
|
| ASSESSMENT |
| 12-item Tobacco Craving Questionnaire (TCQ-12) |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |
